Ondansetron
- Product NDC
- 0641-6079
- 11-digit product format
- 006416079
- Labeler code
- 0641
- Product ID
- 0641-6079_9e948e67-37a3-48ca-ae91-a73efea950aa
- Type
- HUMAN PRESCRIPTION DRUG
- Nonproprietary name
- Ondansetron
- Dosage form
- INJECTION
- Route
- INTRAMUSCULAR; INTRAVENOUS
- Labeler
- Hikma Pharmaceuticals USA Inc.
- Application
- ANDA077365
- Marketing category
- ANDA
- Marketing start
- 2006-12-26
- Substance
- ONDANSETRON HYDROCHLORIDE
- Active strength
- 2 mg/mL
- Pharmacologic classes
- Serotonin 3 Receptor Antagonists [MoA], Serotonin-3 Receptor Antagonist [EPC]
- NDC exclude flag
- No
- Listing certified through
- 2027-12-31
- Current FDA listing
- Yes
Additional Listing Data#
- Finished product
- Yes
- Brand name base
- Ondansetron
- Listing expiration
- 2027-12-31
Active Ingredients#
| Ingredient | Strength |
|---|---|
| ONDANSETRON HYDROCHLORIDE | 2 mg/mL |
Harmonized Identifiers#
| Field | Values |
|---|---|
| Unii | NMH84OZK2B |
| Rxcui | 283504, 1740467 |
DailyMed Product Concepts#
| Product concept | Relation | Version | Effective |
|---|---|---|---|
| d9bd4853-037c-6968-f4d4-9bb9a0efd1ea | Product name | 2 | 20250722 |
| 32e23bc9-ce14-4555-bb6d-bcb654d7d296 | Product name | 1 | 20201015 |
| e459f50a-1553-4aab-b6bd-1e5f0c211c49 | Product name | 1 | 20201015 |
| 909480fe-0d18-c1c1-a658-0bd9a7131822 | Product name | 5 | 20170829 |
DailyMed Package Descriptions#
| Package NDC | Product | Description | Form | Quantity | Strength | SPL version |
|---|---|---|---|---|---|---|
| 0641-6079-01 | Ondansetron | 20 mL in 1 CARTON | INJECTION | 20 | 17 |
DailyMed Billing Units#
| Package NDC | Billing unit | Product NDC | DailyMed indexing SPL | SPL version | Effective |
|---|---|---|---|---|---|
| 0641-6079-01 | ML - Milliliter | 0641-6079 | 0dc5eac6-db16-490a-a3ef-13d6331810dd | 1 | 2012-07-24 |
DailyMed Socrata Ingredients#
| Ingredient | Type | UNII | DailyMed label | SPL version | Uploaded |
|---|---|---|---|---|---|
| ONDANSETRON HYDROCHLORIDE | ACTIVE INGREDIENT | NMH84OZK2B | ONDANSETRON INJECTION [WEST-WARD PHARMACEUTICAL CORP.] | 11 | |
| ONDANSETRON | ACTIVE MOIETY | 4AF302ESOS | ONDANSETRON INJECTION [WEST-WARD PHARMACEUTICAL CORP.] | 11 | |
| CITRIC ACID MONOHYDRATE | INACTIVE INGREDIENT | 2968PHW8QP | ONDANSETRON INJECTION [WEST-WARD PHARMACEUTICAL CORP.] | 11 | |
| METHYLPARABEN | INACTIVE INGREDIENT | A2I8C7HI9T | ONDANSETRON INJECTION [WEST-WARD PHARMACEUTICAL CORP.] | 11 | |
| PROPYLPARABEN | INACTIVE INGREDIENT | Z8IX2SC1OH | ONDANSETRON INJECTION [WEST-WARD PHARMACEUTICAL CORP.] | 11 | |
| SODIUM CHLORIDE | INACTIVE INGREDIENT | 451W47IQ8X | ONDANSETRON INJECTION [WEST-WARD PHARMACEUTICAL CORP.] | 11 | |
| TRISODIUM CITRATE DIHYDRATE | INACTIVE INGREDIENT | B22547B95K | ONDANSETRON INJECTION [WEST-WARD PHARMACEUTICAL CORP.] | 11 | |
| WATER | INACTIVE INGREDIENT | 059QF0KO0R | ONDANSETRON INJECTION [WEST-WARD PHARMACEUTICAL CORP.] | 11 |
DailyMed Dashboard NDC Coverage#
DailyMed RxNorm Mappings#
| RxCUI | RxNorm string | TTY | DailyMed | SPL version |
|---|---|---|---|---|
| 283504 | ondansetron 2 MG/ML Injectable Solution | PSN | c29ca6df-621d-44b6-98fc-b48666573366 | 17 |
| 1740467 | ondansetron 4 MG in 2 ML Injection | PSN | c29ca6df-621d-44b6-98fc-b48666573366 | 17 |
| 1740467 | 2 ML ondansetron 2 MG/ML Injection | SCD | c29ca6df-621d-44b6-98fc-b48666573366 | 17 |
| 283504 | ondansetron 2 MG/ML Injectable Solution | SCD | c29ca6df-621d-44b6-98fc-b48666573366 | 17 |
| 283504 | ondansetron (as ondansetron HCl ) 2 MG/ML Injectable Solution | SY | c29ca6df-621d-44b6-98fc-b48666573366 | 17 |
| 1740467 | ondansetron 4 MG per 2 ML Injection | SY | c29ca6df-621d-44b6-98fc-b48666573366 | 17 |
Packages#
| Package NDC | 11-digit format | Description | Units | Marketing start | Marketing end | Sample | Exclude flag | Status |
|---|---|---|---|---|---|---|---|---|
| 0641-6079-01 | 00641607901 | 20 mL in 1 CARTON (0641-6079-01) | 20 ml | 2006-12-26 | 0000-00-00 | No | No | Current |